China Rush Over? Korean Firms Step Up To Seize Opportunities

Strong BIO Presence Signals Intent

 
• By Jung Won Shin

Falling foreign investment and increasing business uncertainties in China could present new opportunities for the Korean biopharma sector, which is stepping up globalization and R&D efforts to seek growth.

business investment
Will Korean Biophamas Benefit From Derailed China Investment Funds? • Source: Shutterstock

More from South Korea

More from Focus On Asia